TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
Study 0146: A Phase 1a, Double-Blinded, Randomized, Placebo Controlled, Single Ascending Dose (SAD) Study to Evaluate the Safety, Tolerability, and Systemic Exposure of TD-3504 in Healthy Subjects and Subjects With Ulcerative Colitis (UC) Study 0146: A Phase 1a, Double-Blinded, Randomized, Placebo Controlled, Single Ascending Dose (SAD) ...
Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects